Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Evolution of Risk Behaviors, Sexually Transmitted Infections and PrEP Care Continuum in a Hospital-Based PrEP Program in Barcelona, Spain: A Descriptive Study of the First 2 Years' Experience.
Infect Dis Ther. 2023 Feb;12(2):425-442. doi: 10.1007/s40121-022-00733-6. Epub 2022 Dec 15.
Infect Dis Ther. 2023.
PMID: 36520330
Free PMC article.
Chemsex Practices in PrEP: Beyond Addiction and Risk Toward a Healthy Sex Life-Baseline Experiences from a Hospital-Based PrEP Program in Barcelona, Spain.
De La Mora L, Ugarte A, Martínez-Rebollar M, De Lazzari E, García-Hernández D, Font G, De Loredo N, Solbes E, Miquel L, Blanch J, Torres B, Riera J, Chivite I, Ambrosioni J, Inciarte A, González-Cordón A, Martínez E, Blanco JL, Mallolas J, Laguno M.
De La Mora L, et al. Among authors: solbes e.
AIDS Behav. 2022 Dec;26(12):4055-4062. doi: 10.1007/s10461-022-03730-5. Epub 2022 Jun 22.
AIDS Behav. 2022.
PMID: 35732910
Free PMC article.
Item in Clipboard
Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate for Nonoccupational HIV-1 Postexposure Prophylaxis: A Prospective Open-Label Trial (DORAVIPEP).
Inciarte A, Ugarte A, Martínez-Rebollar M, Torres B, Fernández E, Berrocal L, Laguno M, De la Mora L, De Lazzari E, Callau P, Chivite I, González-Cordón A, Solbes E, Rico V, Barrero L, Blanco JL, Martínez E, Ambrosioni J, Mallolas J; DORAVIPEP Study Group.
Inciarte A, et al. Among authors: solbes e.
Open Forum Infect Dis. 2023 Jul 19;10(8):ofad374. doi: 10.1093/ofid/ofad374. eCollection 2023 Aug.
Open Forum Infect Dis. 2023.
PMID: 37539061
Free PMC article.
Item in Clipboard
Tolerability of bictegravir/tenofovir alafenamide/emtricitabine versus dolutegravir/lamivudine as maintenance therapy in a real-life setting.
Rocabert A, Borjabad B, Berrocal L, Blanch J, Inciarte A, Chivite I, Gonzalez-Cordon A, Torres B, Ambrosioni J, Martinez-Rebollar M, Laguno M, De La Mora L, Foncillas A, Sempere A, Rodriguez A, Solbes E, Llobet R, Miro JM, Mallolas J, Blanco JL, De Lazzari E, Martinez E.
Rocabert A, et al. Among authors: solbes e.
J Antimicrob Chemother. 2023 Dec 1;78(12):2961-2967. doi: 10.1093/jac/dkad338.
J Antimicrob Chemother. 2023.
PMID: 37875023
Item in Clipboard
Efficacy and safety of raltegravir plus lamivudine maintenance therapy.
Borjabad B, Inciarte A, Chivite I, Gonzalez-Cordon A, Mosquera M, Hurtado C, Rovira C, Gonzalez T, Sempere A, Torres B, Calvo J, De La Mora L, Martinez-Rebollar M, Laguno M, Foncillas A, Ambrosioni J, Blanch J, Rodriguez A, Solbes E, Llobet R, Berrocal L, Mallolas J, Miro JM, Alcami J, Blanco JL, Sanchez-Palomino S, De Lazzari E, Martinez E.
Borjabad B, et al. Among authors: solbes e.
J Antimicrob Chemother. 2024 Feb 1;79(2):255-261. doi: 10.1093/jac/dkad364.
J Antimicrob Chemother. 2024.
PMID: 38039097
Clinical Trial.
Item in Clipboard
Biological responses to asbestos inhalation and pathogenesis of asbestos-related benign and malignant disease.
Solbes E, Harper RW.
Solbes E, et al.
J Investig Med. 2018 Apr;66(4):721-727. doi: 10.1136/jim-2017-000628. Epub 2018 Jan 6.
J Investig Med. 2018.
PMID: 29306869
Review.
Item in Clipboard
Economic impact of ovarian stimulation with corifollitropin alfa versus conventional daily gonadotropins in oocyte donors: a randomized study.
Cruz M, Alamá P, Muñoz M, Collado D, Blanes C, Solbes E, Requena A.
Cruz M, et al. Among authors: solbes e.
Reprod Biomed Online. 2017 Jun;34(6):605-610. doi: 10.1016/j.rbmo.2017.03.003. Epub 2017 Mar 14.
Reprod Biomed Online. 2017.
PMID: 28366518
Clinical Trial.
Item in Clipboard
Cite
Cite